Eletriptan API Manufacturer & Supplier in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Eletriptan API

Eletriptan is a selective serotonin 5-HT1B/1D receptor agonist belonging to the triptan class of antimigraine medicines. It is an orally active small-molecule pharmaceutical ingredient developed for the acute treatment of migraine attacks, with or without aura.

Eletriptan works primarily by activating serotonin 5-HT1B and 5-HT1D receptors. This produces constriction of certain intracranial blood vessels and inhibits the release of vasoactive neuropeptides involved in migraine pathophysiology.

Eletriptan is available pharmaceutically as eletriptan hydrobromide, the salt form used in marketed tablets. The free base has CAS Number 143322-58-1, while eletriptan hydrobromide is identified by CAS Number 177834-92-3.

Eletriptan API Manufacturer and Supplier

Eletriptan API is a pharmaceutical active ingredient belonging to the triptan class. It is used in pharmaceutical formulation development for products intended for the acute treatment of migraine.

Eletriptan has the molecular formula C22H26N2O2S and molecular weight approximately 382.52 g/mol. The hydrobromide salt has the molecular formula C22H27BrN2O2S and molecular weight approximately 463.44 g/mol.

Key Features of Eletriptan

  • Selective serotonin 5-HT1B/1D receptor agonist
  • Triptan-class antimigraine compound
  • Orally active small molecule
  • Used for acute migraine treatment
  • Available as eletriptan hydrobromide in pharmaceutical formulations
  • Molecular formula: C22H26N2O2S
  • Molecular weight: 382.52 g/mol
  • Free-base CAS Number: 143322-58-1
  • Hydrobromide CAS Number: 177834-92-3

Mechanism of Action

Eletriptan binds with high affinity to serotonin 5-HT1B and 5-HT1D receptors. Activation of these receptors contributes to cranial vasoconstriction and inhibition of trigeminal neuropeptide release, helping to interrupt the processes associated with an acute migraine attack.

Pharmaceutical Applications

Eletriptan is primarily associated with:

  • Acute treatment of migraine
  • Migraine with aura
  • Migraine without aura
  • Pharmaceutical formulation development
  • Triptan-related pharmaceutical research

It is intended for acute treatment rather than preventive treatment of migraine.

Eletriptan API Quality

Eletriptan API should be manufactured, tested and released according to the applicable approved specification and pharmaceutical quality requirements.

Relevant quality attributes may include:

  • Identification
  • Assay
  • Related substances
  • Residual solvents
  • Water content
  • Residue on ignition
  • Elemental impurities
  • Polymorphic form
  • Particle characteristics
  • Other product-specific analytical parameters

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Heavy Metals NMT 20 ppm
pH (1% Solution) 2.0 – 4.0
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 1.0%
Melting Point 150°C – 154°C
Get Bulk Quote via WhatsApp